Emergent BioSolutions is a specialty pharmaceutical and life sciences enterprise that focuses heavily on developing, manufacturing, and commercializing medical countermeasures against public health threats, emerging infectious diseases, and chemical, biological, radiological, or nuclear (CBRN) accidents. It operates as a vital business-to-government (B2G) and commercial supplier, providing emergency vaccines and overdose-reversal treatments.